Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 8, Issue 2, Pages 114-126
Publisher
Springer Nature
Online
2011-10-18
DOI
10.1038/nrendo.2011.156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Prevalence of Obesity and Glucose Intolerance in Youth Treated with Second—Generation Antipsychotic Medications
- (2017) Constadina Panagiotopoulos et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Metabolic syndrome in people with schizophrenia: a review
- (2015) MARC DE HERT et al. World Psychiatry
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
- (2015) MARC DE HERT et al. World Psychiatry
- Metabolic Screening in Children Receiving Antipsychotic Drug Treatment
- (2012) Elaine H. Morrato et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia
- (2011) D. Vancampfort et al. ACTA PSYCHIATRICA SCANDINAVICA
- Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism
- (2011) Kyoung-Jin Oh et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
- (2011) Debra L. Foley et al. ARCHIVES OF GENERAL PSYCHIATRY
- Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation
- (2011) M. De Hert et al. BRITISH JOURNAL OF PSYCHIATRY
- Mechanisms and Genetics of Antipsychotic-Associated Weight Gain
- (2011) S L Balt et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
- (2011) M. De Hert et al. EUROPEAN PSYCHIATRY
- QT Interval Duration and Dispersion in Children and Adolescents Treated With Ziprasidone
- (2011) Christoph U. Correll et al. JOURNAL OF CLINICAL PSYCHIATRY
- Sudden Deaths in Psychiatric Patients
- (2011) Peter Manu et al. JOURNAL OF CLINICAL PSYCHIATRY
- National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007
- (2011) Jonathan S. Comer et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Switching among Antipsychotics in Everyday Clinical Practice: Focus on Ziprasidone
- (2011) Alessandro Rossi et al. POSTGRADUATE MEDICINE
- Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: A population-based study
- (2011) Chun-Hui Liao et al. SCHIZOPHRENIA RESEARCH
- The association between weight change and symptom reduction in the CATIE schizophrenia trial
- (2011) Eric Hermes et al. SCHIZOPHRENIA RESEARCH
- Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)
- (2010) S. H. L. Thomas et al. ACTA PSYCHIATRICA SCANDINAVICA
- Antipsychotic-associated all-cause and cardiac mortality: what should we worry about and how should the risk be assessed?
- (2010) Christoph U. Correll et al. ACTA PSYCHIATRICA SCANDINAVICA
- Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)
- (2010) Brian L. Strom et al. AMERICAN JOURNAL OF PSYCHIATRY
- National Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry
- (2010) Ramin Mojtabai et al. ARCHIVES OF GENERAL PSYCHIATRY
- Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs
- (2010) Elaine H. Morrato et al. ARCHIVES OF GENERAL PSYCHIATRY
- Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials
- (2010) Christoph U Correll et al. BIPOLAR DISORDERS
- Treatment with antipsychotics and the risk of diabetes in clinical practice
- (2010) Lars Vedel Kessing et al. BRITISH JOURNAL OF PSYCHIATRY
- Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics
- (2010) Mehrul Hasnain et al. Current Diabetes Reports
- Cardiovascular aspects of antipsychotics
- (2010) Thomas J Raedler CURRENT OPINION IN PSYCHIATRY
- Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons
- (2010) David Fraguas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
- (2010) C.U. Correll EUROPEAN PSYCHIATRY
- Management of antipsychotic-related weight gain
- (2010) Lawrence Maayan et al. Expert Review of Neurotherapeutics
- MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study
- (2010) Ruud van Winkel et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- The METEOR study of diabetes and other metabolic disorders in patients with schizophrenia treated with antipsychotic drugs. I. Methodology
- (2010) Marc De Hert et al. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH
- Triglyceride/High-Density Lipoprotein Cholesterol Ratio
- (2010) Xiaoduo Fan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Past and Present Progress in the Pharmacologic Treatment of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
- (2010) Jimmi Nielsen et al. NEUROPSYCHOPHARMACOLOGY
- Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis
- (2010) Lawrence Maayan et al. NEUROPSYCHOPHARMACOLOGY
- Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design
- (2010) Roberto Coccurello et al. PHARMACOLOGY & THERAPEUTICS
- Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia
- (2010) Davy Vancampfort et al. PSYCHIATRY RESEARCH
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- MTHFR and risk of metabolic syndrome in patients with schizophrenia
- (2010) Ruud van Winkel et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
- (2010) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
- Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs
- (2010) Tim Moons et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic drugs and obesity
- (2010) Christoph U. Correll et al. TRENDS IN MOLECULAR MEDICINE
- Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents
- (2009) Dan W. Haupt et al. AMERICAN JOURNAL OF PSYCHIATRY
- Somatic Hospital Contacts, Invasive Cardiac Procedures, and Mortality From Heart Disease in Patients With Severe Mental Disorder
- (2009) Thomas Munk Laursen et al. ARCHIVES OF GENERAL PSYCHIATRY
- Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare
- (2009) Stephen Kisely et al. BRITISH JOURNAL OF PSYCHIATRY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
- (2009) Mario Álvarez-Jiménez et al. CNS DRUGS
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes
- (2009) DIABETES CARE
- Does physical activity modify the risk of obesity for type 2 diabetes: a review of epidemiological data
- (2009) Li Qin et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins
- (2009) F.C.J. Starrenburg et al. EUROPEAN PSYCHIATRY
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
- (2009) M. De Hert et al. EUROPEAN PSYCHIATRY
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Psychiatric Diagnosis as an Independent Risk Factor for Metabolic Disturbances
- (2009) Ruud van Winkel et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Effects of Undertreated Chronic Medical Illnesses in Patients With Severe Mental Disorders
- (2009) Andrea Fagiolini et al. JOURNAL OF CLINICAL PSYCHIATRY
- Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent?
- (2009) Viktoria Simon et al. JOURNAL OF CLINICAL PSYCHIATRY
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- The incidence of diabetes in atypical antipsychotic users differs according to agent-results from a multisite epidemiologic study
- (2009) Marianne Ulcickas Yood et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- (2009) Gavin P Reynolds et al. PHARMACOLOGY & THERAPEUTICS
- Weight gain in antipsychotic-naive patients: a review and meta-analysis
- (2009) I. Tarricone et al. PSYCHOLOGICAL MEDICINE
- Weight effects associated with antipsychotics: A comprehensive database analysis
- (2009) Bruce Parsons et al. SCHIZOPHRENIA RESEARCH
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
- (2008) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotics and Diabetes: An Age-Related Association
- (2008) Ariel Hammerman et al. ANNALS OF PHARMACOTHERAPY
- Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents
- (2008) Roger S. McIntyre et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder
- (2008) Ruud van Winkel et al. BIPOLAR DISORDERS
- First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis
- (2008) M. Smith et al. BRITISH JOURNAL OF PSYCHIATRY
- Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder
- (2008) Victoria L. Vetter et al. CIRCULATION
- Adverse events in children and adolescents treated with antipsychotic medications
- (2008) Jeanette M. Jerrell et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder
- (2008) Giuseppe Maina et al. JOURNAL OF AFFECTIVE DISORDERS
- Quality of Care for Cardiovascular Disease-related Conditions in Patients with and without Mental Disorders
- (2008) Amy M. Kilbourne et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
- (2008) S Leucht et al. MOLECULAR PSYCHIATRY
- Waist Circumference Measurement in Clinical Practice
- (2008) Rosane Ness-Abramof et al. NUTRITION IN CLINICAL PRACTICE
- Cardiovascular Monitoring and Stimulant Drugs for Attention-Deficit/Hyperactivity Disorder
- (2008) J. M. Perrin et al. PEDIATRICS
- A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study
- (2008) Celso Arango et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now